Application of Plasma Circulating KRAS Mutations As a Predictive Biomarker for Targeted Treatment of Pancreatic Cancer.
Cancer Science(2024)
Key words
circulating tumor DNA,KRAS,KRAS G12C inhibitor,pancreatic ductal adenocarcinoma,patient-derived organoid
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined